During the past decade, Lakeshore Primary Care Associate conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lakeshore Primary Care Associate" are "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "Lakeshore Primary Care Associate" in a lesser frequency.

Most popular intervention types in "Lakeshore Primary Care Associate" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "Placebo (for Fenofibrate)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lakeshore Primary Care Associate" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Lakeshore Primary Care Associate". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Lakeshore Primary Care Associate, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lakeshore Primary Care Associate, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".